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subspecies paratuberculosis (MAP)—the 
cause of Johne’s disease.
“No one else in the world has been able 
to find such a specific antibody that binds 
only to MAP strains, until now,” says 
Bannantine, who’s in NADC’s Infectious 
Bacterial Diseases Research Unit.
A Wild Goose Chase
After identifying the new antibody—
called “17A12”—from mice immunized 
with MAP strain K-10, scientists decided to 
dig a little deeper to determine the protein 
this novel antibody binds to.
Initially, researchers believed they had 
found a new gene encoding the antibody-
binding protein that was not originally 
identified in the MAP K-10 genome. They 
called it “UP1” (Unique Protein 1).
Before a disease can be 
treated, it must first be 
identified. But that’s not always 
easy, especially in the case of Johne’s 
disease, which affects cattle, sheep, goats, 
deer, and other ruminants.
Johne’s disease—also known as “para-
tuberculosis”—is a costly, contagious 
disease that causes diarrhea, reduced feed 
intake, weight loss, and sometimes death. 
Annual estimated losses to cattle producers 
range from $40 to $227 per infected animal. 
For the U.S. dairy industry alone, losses 
exceed $220 million each year.
For years, scientists have been hampered 
by the fact that any antibody—a protein 
produced by the immune system to fight 
infections and foreign substances—used to 
detect the Johne’s disease bacterium also 
reacted to other environmental bacteria or 
maybe the pathogen responsible for bovine 
tuberculosis. This caused false-positive 
test results.
“You may think cattle are infected, 
based on a positive antibody test result, 
but they may simply have been exposed 
to nonpathogenic mycobacteria that’s 
ubiquitously present in the environment,” 
says microbiologist John Bannantine at 
the Agricultural Research Service’s Na-
tional Animal Disease Center (NADC) in 
Ames, Iowa.
That problem, however, is now history. 
Bannantine and his colleagues at NADC 
have found an antibody that’s 100 percent 
specific in detecting Mycobacterium avium 
“In 2005, we sequenced the genome of 
a MAP cattle strain, and then annotated 
it—finding all the genes and identifying 
where they start and where they stop,” 
Bannantine says. “But the 17A12 antibody 
bound to a protein encoded by a gene that 
was not annotated in the MAP genome. 
This was unusual, but we were excited 
about finding a potentially new gene.”
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At the National Animal Disease Center, in Ames, Iowa, microbiologists John Bannantine and Judy 
Stabel review results  of a western blot experiment using the MAP specific monoclonal antibody. 
Detecting 
Johne’s  
Disease  
Easier
ARS scientists at Ames, Iowa, have discovered a 
specific antibody that will help develop a test for 
the Johne’s disease bacterium in cattle.
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To confirm this unusual finding, Ban-
nantine developed additional monoclonal 
antibodies to the UP1 protein. Only one 
of these new antibodies reacted with the 
native protein produced by MAP. It also 
happened to bind to the same area of the 
protein as the initial antibody—17A12.
“When we expressed the UP1 protein 
in E. coli, it reacted with the monoclonal 
antibody, and we saw this as confirmation 
that UP1 was real, even though it wasn’t an-
notated in the genome,” Bannantine says.
Finding the Right Protein
But some of the data just didn’t add up. 
After additional experiments, it turned out 
that UP1 was not a real gene after all.
“It completely blew my mind. I had 
never had a day in the lab like that where 
there was such a revelation,” Ban-
nantine says. “When we first got 
the results contradicting UP1 as 
a real gene, it was scary because 
we thought we had made some 
big mistakes. Then slowly all the 
pieces started to fit together, and 
we knew what we actually had. 
It was incredible.”
Although UP1 was not a gene, 
it had an epitope—a portion of a 
molecule to which an antibody 
binds. This epitope mimicked a 
similar epitope in the real gene.
In fact, Bannantine says, out of 
the seven amino acids that make 
up the epitope in UP1, one amino 
acid was different from the real 
epitope encoded by MAP1025, 
a gene that was annotated in the 
MAP genome.
With this new discovery, sci-
entists not only found the real 
antibody-binding protein, but 
could now focus on the reason 
why the new antibody was so 
specific to MAP.
Solving the Mystery of 
Specificity
A sequence analysis showed 
that the MAP1025 gene was pres-
ent in the non-MAP strains, which 
did not explain why the antibody 
was specific to M. paratubercu-
losis and not to environmental 
contaminants. To find the answer, 
Bannantine sequenced MAP1025 
from several paratuberculosis and non-
paratuberculosis strains.
He found a single nucleotide change in 
the sequence encoding the epitope. This 
change affected the first amino acid out of 
the seven that make up the epitope, which 
is what created the specificity of M. para-
tuberculosis, Bannantine says.
Researchers can now accurately detect 
the Johne’s disease pathogen and know for 
certain that it’s not a contaminant.
 “We finally have a specific antibody to 
detect live mycobacteria in the tissues or 
feces of cattle. This could never have been 
done before,” Bannantine says.
Scientists have received a patent for the 
new antibody and are moving forward to 
develop diagnostic tests that will confirm 
the presence of the Johne’s disease 
bacterium.
“We can now use this antibody to enrich 
the bacterium when it is present in low con-
centrations, such as in unpasteurized milk 
samples,” Bannantine says. “Improved 
testing and diagnostics is really the big 
benefit of this antibody.”—By Sandra 
Avant, ARS.
This research is part of Animal Health, 
an ARS national program  (#103) described 
at www.nps.ars.usda.gov.
John Bannantine is in the USDA-ARS 
Infectious Bacterial Diseases Research 
Unit, National Animal Disease Center, 
1920 Dayton Ave., Ames, IA 50010; (301) 
337-7340, john.bannantine@ars.usda.
gov.*
Vaccines play a critical role in reducing the severity of Johne’s disease, but using 
them can become a balancing act if the vaccine cross-reacts with tests for other 
cattle diseases like bovine tuberculosis (TB)—an issue in states where wildlife are 
tracking TB back into dairy herds.
“Producers are concerned that if they vaccinate against Johne’s, they will not be 
able to discriminate whether their herd has bovine tuberculosis or Johne’s,” says 
microbiologist Judy Stabel, in the National Animal Disease Center’s Infectious 
Bacterial Disease Research Unit.
Stabel looked at the cross reactivity of an effective U.S. commercial vaccine with 
TB diagnostic tests. Several calves were vaccinated against Johne’s disease, 
and blood samples were taken over a period of 1 year. Immune and serological 
responses of calves were then measured using novel TB diagnostics that will be 
available in the future.
“These new serology tests for TB diagnostics are very promising,” Stabel says. 
“They’re similar to the stick pregnancy tests for humans, except you use serum.”
The tests consist of small sticks coated with bovine TB antigen. The antibody in 
the serum reacts to the antigen if it is positive.
With vaccinated calves, no reactivity was found using the TB tests, which is good 
because it means that those tests will not wrongly identify cattle with Johne’s dis-
ease as being positive for bovine TB, Stabel says.
“We also did skin testing, which is one of the main tests in the field for bovine tu-
berculosis, and found similar results,” she adds.
The results of these studies showed that calves could be vaccinated against Johne’s 
disease without interfering with bovine TB diagnostics.
A major advantage of the new serologic tests is the cost and ease of use, Stabel 
says. “Animals can be handled one time to obtain a blood sample rather than 
being handled twice to administer and read a skin test. That reduces veterinary 
costs.”—By Sandra Avant, ARS.
Judy Stabel is in the USDA-ARS Infectious Bacterial Diseases Research Unit, Na-
tional Animal Disease Center, 1920 Dayton Ave., Ames, IA 50010; (301) 337-7304, 
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